Notch signaling pathway: architecture, disease, and therapeutics

By Binghan Zhou, Wan-Ying Lin, Yaling Long, Yunkai Yang, Huan Zhang, Kongming Wu, Q. Chu. Signal Transduction and Targeted Therapy, 2022

956 citations recorded by the source corpus.

The NOTCH gene was identified approximately 110 years ago. Classical studies have revealed that NOTCH signaling is an evolutionarily conserved pathway. NOTCH receptors undergo three cleavages and translocate into the nucleus to regulate the transcription of target genes. NOTCH signaling deeply participates in the development and homeostasis of multiple tissues and organs, the aberration of which results in cancerous and noncancerous diseases. However, recent studies indicate that the outcomes of NOTCH signaling are changeable and highly dependent on context. In terms of cancers, NOTCH signaling can both promote and inhibit tumor development in various types of cancer. The overall performance of NOTCH-targeted therapies in clinical trials has failed to meet expectations. Additionally, NOTCH mutation has been proposed as a predictive biomarker for immune checkpoint blockade therapy in many cancers. Collectively, the NOTCH pathway needs to be integrally assessed with new perspectives to inspire discoveries and applications. In this review, we focus on both classical and the latest findings related to NOTCH signaling to illustrate the history, architecture, regulatory mechanisms, contributions to physiological development, related diseases, and therapeutic applications of the NOTCH pathway. The contributions of NOTCH signaling to the tumor immune microenvironment and cancer immunotherapy are also highlighted. We hope this review will help not only beginners but also experts to systematically and thoroughly understand the NOTCH signaling pathway.

Subfields: Immunology, Immunology and Allergy

View Paper: https://www.semanticscholar.org/paper/7f061fb37d1c9358ae9f778c48a87428d46c907f

How researchers see this paper

The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.

  1. Mingxi Lin
  2. Yizi Jin
  3. Xin Shen
  4. C. Zeng
  5. Qing Guo
  6. Jian Zhang
  7. Teng Zhou
  8. Xinyu Chen

Citations in the corpus